Orthostatic Cerebral Hypoperfusion Syndrome by Peter Novak
February 2016 | Volume 8 | Article 221
Original research
published: 16 February 2016
doi: 10.3389/fnagi.2016.00022
Frontiers in Aging Neuroscience | www.frontiersin.org
Edited by: 
Milica S. Prostran, 
University of Belgrade, Serbia
Reviewed by: 
Tatjana Potpara, 
University of Belgrade, Serbia 
Branislava M. Medic, 
University of Belgrade, Serbia
*Correspondence:
Peter Novak  
pnovak2@partners.org
Received: 10 December 2015
Accepted: 28 January 2016
Published: 16 February 2016
Citation: 
Novak P (2016) Orthostatic Cerebral 
Hypoperfusion Syndrome. 
Front. Aging Neurosci. 8:22. 
doi: 10.3389/fnagi.2016.00022
Orthostatic cerebral hypoperfusion 
syndrome
Peter Novak*
Department of Neurology, Brigham and Women’s Faulkner Hospital, Harvard Medical School, Boston, MA, USA
Objective: Orthostatic dizziness without orthostatic hypotension is common but under-
lying pathophysiology is poorly understood. This study describes orthostatic cerebral 
hypoperfusion syndrome (OCHOs). OCHOs is defined by (1) abnormal orthostatic drop 
of cerebral blood flow velocity (CBFv) during the tilt test and (2) absence of orthostatic 
hypotension, arrhythmia, vascular abnormalities, or other causes of abnormal ortho-
static CBFv.
Methods: This retrospective study included patients referred for evaluation of unexplained 
orthostatic dizziness. Patients underwent standardized autonomic testing, including 
10 min of tilt test. The following signals were monitored: heart rate, end tidal CO2, blood 
pressure, and CBFv from the middle cerebral artery using transcranial Doppler. Patients 
were screened for OCHOs. Patients who fulfilled the OCHOs criteria were compared to 
age- and gender-matched controls.
results: From 1279 screened patients, 102 patients (60/42 women/men, age 
51.1 ± 14.9, range 19–84 years) fulfilled criteria of OCHOs. There was no difference in 
baseline supine hemodynamic variables between OCHOs and the control group. During 
the tilt, mean CBFv decreased 24.1 ± 8.2% in OCHOs versus 4.2 ± 5.6% in controls 
(p < 0.0001) without orthostatic hypotension in both groups. Supine mean blood pres-
sure (OCHOs/controls, 90.5 ± 10.6/91.1 ± 9.4 mmHg, p = 0.62) remained unchanged 
during the tilt (90.4 ± 9.7/92.1 ± 9.6 mmHg, p = 0.2). End tidal CO2 and heart rate 
responses to the tilt were normal and equal in both groups.
conclusion: OCHOs is a novel syndrome of low orthostatic CBFv. Two main patho-
physiological mechanisms are proposed, including active cerebral vasoconstriction and 
passive increase of peripheral venous compliance. OCHOs may be a common cause of 
orthostatic dizziness.
Keywords: OchOs, POTs, Oh, orthostatic, hypoperfusion, hypotension, QasaT
Abbreviations: BP, blood pressure; CBFv, cerebral blood flow velocity; HR, heart rate; OH, orthostatic hypotension, OCHOs, 
orthostatic cerebral hypoperfusion syndrome; POTS, postural tachycardia syndrome; QASAT, quantitative scale for grading of 
cardiovascular autonomic reflex tests and small fibers from skin biopsies; SVD, small vessel disease.
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inTrODUcTiOn
Orthostatic dizziness is common, affecting 2–19% of elderly 
(Ensrud et  al., 1992; Hoffman et  al., 1999; Wu et  al., 2008). 
Orthostatic dizziness may be associated with orthostatic hypoten-
sion that has prevalence 5–30%. However, most population-based 
studies showed dissociation between orthostatic dizziness and 
orthostatic hypotension (Ensrud et al., 1992; Colledge et al., 1996; 
Ooi et al., 1997; Wu et al., 2008). Up to 31% of elderly (Colledge 
et al., 1996) or nearly 20% of nursing home residents (Ooi et al., 
1997) with dizziness or lightheadedness on standing do not 
have orthostatic blood pressure changes. Orthostatic dizziness is 
associated with age, medication use, and comorbid diseases, such 
as diabetes, stroke, vestibular dysfunction, vision impairment, 
disturbances in proprioception in addition to orthostatic blood 
pressure changes (Lipsitz, 1985; Mader et al., 1987; Sloane and 
Baloh, 1989; Sloane et al., 1989; Ensrud et al., 1992; Katsarkas, 
1994). Orthostatic dizziness may be due to cerebral hypoperfu-
sion (Wollner et al., 1979; Lipsitz, 1989; Sloane and Baloh, 1989; 
Sloane et al., 1989; Ohashi et al., 1991; Katsarkas, 1994; Novak 
et al., 1998). In most cases, the hemodynamic mechanisms lead-
ing to orthostatic dizziness without orthostatic hypotension are 
unknown.
Recently, validated Quantitative Scale for Grading of 
Cardiovascular Autonomic Reflex Tests and Small Fibers from 
Skin Biopsies (QASAT) (Novak, 2015) grades abnormalities in 
orthostatic blood pressure in patients with autonomic failure 
that is typically associated with orthostatic symptoms, including 
dizziness. QASAT also evaluates cerebral orthostatic hypoperfu-
sion by scoring cerebral blood flow velocity (CBFv) during the 
tilt test. The QASAT validation study showed that many subjects 
without orthostatic hypotension had reduced orthostatic CBFv 
[Fig. 1G and 1H in Novak (2015)]. This observation suggests that 
orthostatic cerebral hypoperfusion may exist without orthostatic 
hypotension in sizeable number of patients with orthostatic 
symptoms. This study follows the above observation and 
defines orthostatic cerebral hypoperfusion syndrome (OCHOs). 
Underlying hypothesis being tested is that OCHOs is a distinct 
syndrome of low CBFv but without orthostatic hypotension. The 
current study also combines the data used in the QASAT valida-
tion study (Novak, 2015) with more recent population expanding 
significantly number of evaluated patients.
MaTerials anD MeThODs
standard Protocol approvals, 
registrations, and Patient consents
The study was approved by the Institutional Review Board of the 
University of Massachusetts Medical School as a minimal risk 
study and the consent form signature was waived.
study Population
This retrospective, single-center study included consecutive 
patients who underwent autonomic testing between 2008 
and 2014 at the University of Massachusetts Medical School 
Autonomic laboratory. The inclusion criteria were: (1) history 
of orthostatic symptoms, including dizziness, weakness, fatigue, 
visual blurring, vertigo, suboccipital, paracervical or chest pain, 
headaches, dyspnea, palpitations, and low back pain (Low 
et al., 1995); (2) age 18 years or older, and (3) completion of the 
autonomic testing. Exclusion criteria were as follows: (1) history 
of significant arrhythmia, hypovolemia, endocrine disorder, or 
other metabolic derangement or systemic disease associated with 
autonomic failure.
Patient’s electronic records were reviewed for details about 
past medical history, laboratory evaluations, including blood 
work and, as well as the use of medication. The records were 
screened for history of autonomic failure, cardiac arrhythmia, 
and abnormal fluid volume. Neurological examinations were 
reviewed to identify abnormalities in sensory and autonomic 
evaluations. Particular emphasis was placed on identifying ortho-
static hypotension, vestibular dysfunction, prominent vision, and 
proprioceptive impairment that can be associated with orthostatic 
dizziness (Lipsitz, 1985; Mader et  al., 1987; Sloane and Baloh, 
1989; Sloane et al., 1989; Ensrud et al., 1992; Katsarkas, 1994).
Medication that affects autonomic testing or causing orthos-
tatic hypotension was stopped for five half-lives if this was con-
sidered to be safe and discontinuation was tolerated by patients.
autonomic Testing
All testing was performed following established standards 
(Low, 1993; Novak, 2011) and was described in details previ-
ously (Novak, 2011). Cardiovascular reflex tests included deep 
breathing, the Valsalva maneuver, and the tilt test. Patients were 
tilted at 70° for 10 min or more following 10 min of supine rest. 
Recorded signals include electrocardiogram, blood pressure, 
respiratory movement using a nasal thermistor, end tidal CO2 
using Capstar-100 (CWE, Inc., Ardmore, PA, USA) and CBFv in 
the middle cerebral artery using Transcranial Doppler. Baseline 
supine blood pressure was obtained intermittently using an 
automated oscillometric blood pressure device Dinamap ProCare 
Monitor 100 (GE, Fairfield, CT) from arm and continuously 
(beat-to-beat) using Finometer® (Finapress Medical Systems, 
Amsterdam, Netherlands) from the third finger. During the 
tilt test, blood pressure was obtained every minute using the 
Dinamap ProCare device and continuously using Finometer®. 
The Dinamap obtained blood pressure served as a reference for 
the Finometer-based blood pressure. Finometer-based blood 
pressure was calibrated with the Dinamap-based blood pressure.
The temporal acoustic window with a 2 MHz probe was used 
for acquisition of CBFv using a MultiDop T (DWL, Singen, 
Germany). The left middle cerebral artery has been identified at 
an insonation depth from 45 to 65 mm. After the optimal flow 
signal has been detected, transducer has been attached to head 
with a plastic head frame with a three-dimensional positioner to 
maintain a tight transducer fixation at constant depth and angle 
of insonation. Continuous Trancranial Doppler monitoring has 
been performed during the supine baseline period and the tilt. 
Signals were recorded using LabChart 7 system (ADInstruments 
Inc., Colorado Springs, CO, USA) and sampled at 400 Hz.
Normative data for CBFv at both supine and tilt test are age, 
gender, and the tilt duration dependent. In healthy subjects, the 
CBFv is either unchanged or there can be a mild drop in CBFv 
TaBle 1 | cerebral blood flow category of QasaT.
results grading Value Definitiona
15. Blood flow response to tilt
Normal 0
Mild 1,2
Abnormal Moderate 3–4
Severe >4
Using mean CBFV. CBFV should be measured at baseline, and at 1, 5, and 10 min of tilt.
aAt each measurement, assign the value 0 for normal results. Abnormal results are 
defined as CBFV less than normal limit. Normal limit is defined as follows:
At 1 min: normal decline in CBFV ≥ 90% of baseline. Assign 1 for CBFV 80–89% of 
baseline, 2 for 70–79% of baseline, and 3 for <70% of baseline.
At 5 min: normal decline in CBFV ≥ 89% of baseline. Assign 1 for CBFV 79–88% of 
baseline, 2 for 69–78% of baseline, and 3 for <69% of baseline.
At 10 min: normal decline in CBFV ≥ 86% of baseline. Assign 1 for CBFV 77–85% of 
baseline, 2 for 67–76% of baseline, and 3 for <67% of baseline. Total score is obtained 
by sum of all scores. Revised after (Novak, 2015).
February 2016 | Volume 8 | Article 223
Novak OCHOs
Frontiers in Aging Neuroscience | www.frontiersin.org
during the tilt. The criteria for normal drop of the mean CBFv 
during tilt test are equal to 90/% (1st minute), 89% (5th minute), 
and 85% (10th minute) of the tilt where baseline is equal to 100% 
(Novak, 2015).
Instantaneous heart rate, systolic, mean, diastolic blood pres-
sure, and CBFv were obtained on beat-to-beat basis. Resistance 
index (RI) and cerebral vascular resistance (Novak et al., 1998) 
were also calculated. RI was defined as (systolic CBFv–diastolic 
CBFv)/systolic CBFv and cerebral vascular resistance was defined 
as mean blood pressure/mean CBFv.
The results of autonomic testing were graded using QASAT 
(Novak, 2015). QASAT is an objective and validated instrument 
that grades cardiovascular reflex tests, including CBFv responses 
to tilt test. QASAT has the following sections: heart rate (includes 
supine heart rate, heart rate response to tilt, and heart rate 
variability), blood pressure (supine and tilt-induced changes, 
including orthostatic hypotension/hypertension), cerebral blood 
flow (both baseline and tilt-induced changes), sudomotor, and 
sensory. QASAT assigns a numeric value to each test result 
that is proportional to the severity of findings, 0 = normal, >0 
abnormal. Higher scores indicate more severe impairment. The 
QASAT criteria were solved by genetic algorithms (Forrest, 1993) 
mimicking process of natural selection and evolution.
The heart rate and blood pressure were analyzed at the supine 
baseline immediately before tilt, and every minute during tilt. 
CBFv, RIs, and end tidal CO2 were analyzed at the supine baseline 
and at the 1st, 5th, and 10th minute of tilt as required by QASAT.
All subjects were observed for presence of orthostatic 
symptoms during tilt test. Orthostatic symptoms were defined 
as: (1) symptoms that occur during the upright position and are 
relieved at supine and (2) symptoms should be present without 
any body movement, both in the supine and upright position. 
The symptoms include dizziness, lightheadedness, visual distur-
bances, hearing disturbances, vertigo, fatigue, sweating, weak-
ness, headache, neck pain, chest pain, palpitations, confusion, 
agitation, memory problems, and inattentiveness (Task Force 
for the Diagnosis and Management of Syncope et al., 2009). The 
symptoms occurring during the movement of the tilt table were 
considered non-orthostatic even if they persisted after secession 
of the tilt table movement.
OchOs Definition
Orthostatic cerebral hypoperfusion syndrome was defined by the 
following inclusion and exclusion criteria. Inclusion criteria were 
(1) abnormal orthostatic drop of mean CBFv fulfilling criteria 
of at least moderate abnormality on the QASAT-CBF (section 
15 > 2, Table 1) obtained at the 1st, 5th, and 10th minute of the 
tilt.
Exclusion criteria include (1) presence of orthostatic hypoten-
sion (QASAT section 7 > 0); (2) presence of arrhythmia defined 
as presence of bradycardia during supine or tilt test (QASAT 
section 1 > 0) or tachycardia during the tilt test (QASAT section 
3 > 1). This criterion also excludes postural tachycardia syndrome 
(POTS) (Novak et al., 1998); (3) unable to complete the 10 min of 
tilt test for any reason including syncope; (4) evidence of hyper-
ventilation during tilt test [end tidal CO2 <  35  mm Hg (Ocon 
et  al., 2009)]; (5) significant structural abnormality on brain 
imaging that can cause significant hemodynamic abnormalities 
using CT or MRI of the brain; (6) any other cause of abnormal 
intracranial velocities, including cerebrovascular accident affect-
ing large vessels, abnormal hematocrit, or volemic status; (7) 
deficit in sensory systems, including vestibular, visual, or proprio-
ceptive impairment that can results in orthostatic dizziness; (8) 
the use of medication that affect autonomic functions, including 
vasoactive medication (vasodilatators or vasoconstrictors) 
during testing. These medications were as follows: any drug for 
treatment of hypertension, including calcium channel blockers, 
beta blockers, nitrates, diuretics, angiotensin-converting enzyme 
inhibitors, anticholinergics, fludrocortisone, pyridostigmine, and 
proamatine.
To satisfy the OCHOs criteria, all inclusion and none of exclu-
sion criteria has to be met.
control subjects
The OCHOs subjects were matched with a control group by age, 
gender, and body mass index from our Autonomic database at 
University of Massachusetts. All controls had normal response 
to tilt in heart rate, blood pressure, and CBFv and respiratory 
variables.
statistical analysis
One-way analysis of variance (ANOVA) was used to test differ-
ences between the OCHOs and non-OCHOs patients at base-
line, 1st minute, 5th minute, and 10th minute of tilt. The initial 
significance level (α) has been set to 0.05. Since there were four 
comparisons, the Bonferroni-corrected significance level was 
adjusted to 0.0125 (obtained by 0.05/4). The effect of tilt within 
group was analyzed by MANOVA for repeated measures. JMP 
12 (Cary, NC, USA) statistical software was used for all statistical 
analyses.
resUlTs
From 1279 patients who were referred for evaluation of unex-
plained orthostatic dizziness, 102 patients satisfied criteria for 
diagnosis of OCHOs. These patients were age- and gender-
matched with the same number of control subjects with 
FigUre 1 | representative examples of normal orthostatic blood pressure and cerebral blood flow velocity (cBFv) (left panel), orthostatic 
hypotension (Oh) with stable cBFv during tilt test (middle panel), and orthostatic cerebral hypoperfusion syndrome (OchOs) (right panel). A patient 
with OH was asymptomatic and had stable CBFv during tilt test indicating preserved cerebral autoregulation. Patient with OCHOs had stable orthostatic blood 
pressure but reduced CBFv during the tilt test. He was dizzy during the tilt test. HR, heart rate; BP, blood pressure.
TaBle 2 | Demographic data.
Variable controls OchOs P
Number of participants, f/m 102,60/42 102,60/42 1
Age, years, range 49.9 ± 15.9, 
18–85
51.1 ± 14.9, 
19–84
0.587
BMI (kg/m2) 27.8 ± 6.5 27.6 ± 6.0 0.768
OCHOs, orthostatic cerebral hypoperfusion syndrome.
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normal responses to tilt. Table  2 shows basic demographic 
of OCHOs group. The following comorbidities were found 
in OCHOs patients: hypertension [n, disease duration (years, 
mean ±  SD)] 21, 5.9 ±  3.4, migraine 14, 5.1 ±  3.4, bipolar 
disorder (14, 4.15 ± 0.9), polyneuropathy (11, 10.4 ± 9.7), dys-
lipidemia (10, 4.4 ± 1.4), diabetes (9, 3.6 ± 1.6), fibromyalgia 
(7, 3.8 ± 1.4), autonomic neuropathy (5, 4.75 ± 4.3), Parkinson 
disease (5, 4.75  ±  2.62), hypothyroidism (4, 4.25  ±  2.1), 
chronic fatigue syndrome (3, 6.3 ± 4.9), anxiety (3, 4.6 ± 0.5), 
and connective tissue disorder (2, 4.5 ± 0.7).
Figure  1 shows a representative example of OCHOs 
with stable orthostatic blood pressure, preserved heart rate 
responses, and reduced CBFv during tilt. An example of severe 
OCHOs is on Figure 2. All OCHOs subjects were symptomatic 
during tilt test and many subjects experienced more than one 
symptom. Tilt-induced symptoms include dizziness or light-
headedness (88%), confusion (2%), headache (10%), tiredness 
(18%), anxiety (23%), generalized weakness (14%), vision 
changes (4%), leg heaviness (15%), and burning sensation at 
distal legs (12%).
Baseline supine Data
Comparing OCHOs and controls, there was no difference in all 
tested variables during the supine period before the tilt (Table 2). 
Both groups had equal blood pressure, heart rate, CBFv, RI, and 
cerebrovascular resistance (CVR).
response to Tilt
In most subjects, there was a progressive drop of systolic, 
mean, and diastolic CBFv’s in both groups during the tilt test 
(Table 3; Figures 1–3). In several OCHOs subjects, the CBFv 
fluctuated throughout the tilt with partial recovery. The drop 
in CBFv was markedly higher in OCHOs group. Mean CBFv 
was reduced to 75.6 ± 8.2% of baseline value that is equal to 
24.4% reduction at the 10th minute of the tilt. The reduction 
of CBFv was equal to 95.8 ± 5.6% (4.2%) in control group at 
the 10th minute of the tilt. The difference between OCHOs 
and controls in CBFv drop was highly significant (p < 0.0001, 
Table  2). RI and cerebral vascular resistance were elevated 
throughout the tilt test in OCHOs group compared to controls. 
There was no difference in blood pressure and heart rate dur-
ing the tilt in both groups. There was no difference in end 
tidal CO2 during baseline supine and during the tilt compared 
both groups.
MANOVA for repeated measures showed significant effect of 
tilt upon end tidal CO2 (p < 0.0001), mean CBFv (p < 0.0001), 
and heart rate (p <  0.0001) but not on systolic/mean/diastolic 
blood pressure at p = 0.05 level at both groups.
All subjects with OCHOs and none of the control subjects had 
orthostatic symptoms during the tilt test.
FigUre 2 | example of severe OchOs. 72-year-old man had diabetes for 2 years and hypertension for 12 years. For last year, he experienced orthostatic 
dizziness and multiple presyncopal episodes. He was not orthostatic at the office visits and psychogenic or cardiac cause of orthostatic symptoms has been 
suspected. Left panel shows the baseline supine period before and after the tilt and the tilt responses. Right panel shows one cardiac cycle of blood pressure and 
cerebral blood flow velocity (CBFv) at the supine baseline and at the end of the tilt. The baseline CBFv gradually declined during tilt test. After the 5th minute of tilt, 
patient became progressively dizzy, confused, and disoriented that coincided with drop of CBFv. He recovered shortly after returning to the supine position when 
also the CBFv returned to the baseline value. There was no evidence cardiac dysrhythmia throughout the testing. There was no orthostatic hypotension during the 
tilt test, in fact, the blood pressure was elevated at the second half of the tilt that corresponds to a period when patient experienced orthostatic symptoms. HR, 
heart rate; BP, blood pressure.
February 2016 | Volume 8 | Article 225
Novak OCHOs
Frontiers in Aging Neuroscience | www.frontiersin.org
DiscUssiOn
Orthostatic cerebral hypoperfusion syndrome is a novel syn-
drome associated with orthostatic hypoperfusion. OCHOs 
patients have stable orthostatic blood pressure, heart rate, and 
respiratory pattern and they still have reduced orthostatic CBFv. 
A decrease in orthostatic CBFv may produce cerebral hypoperfu-
sion and central nervous system symptoms, including dizziness 
(Wollner et al., 1979; Ohashi et al., 1991; Novak et al., 1998; Ocon 
et al., 2009).
Other syndromes that are associated with orthostatic dizzi-
ness or orthostatic intolerance without orthostatic hypotension 
were ruled out in this study. These syndromes include ortho-
static tachycardia syndrome (Low et  al., 2009), inappropriate 
sinus tachycardia (Yusuf and Camm, 2005), large cerebral ves-
sel disease (Ouchi et al., 2001), and deficit in sensory systems, 
including vestibular dysfunction, vision impairment, or disor-
ders in the proprioceptive system (Wu et al., 2008). POTS and 
syncope patients were removed from this study by exclusion 
criteria. There was no evidence of significant sensory deficit in 
our patients that could account for orthostatic dizziness. All 
OCHOs patients had either CT or MRI of the brain and no one 
had evidence of large structural lesion or evidence of cerebral 
large vessel disease.
Transcranial Doppler measures flow velocity instead of blood 
flow. The velocity is not only proportional to flow but also depends 
on the diameter of the insonated vessel. The MCA diameter is 
resistant to change during orthostatic stress (Serrador et al., 2000) 
and, therefore, CBFv is considered a good surrogate of cerebral 
blood flow (Medow et al., 2014).
OCHOs patients had reduced mean CBFv by more than 
20% compared to controls. That reduction is sufficient to 
induce symptoms of cerebral hypoperfusion. Reduction in 
CBFv by 18.7% (Novak et  al., 1998) and 19.5% (Ocon et al., 
2009) from the supine baseline period is associated with signs 
of central nervous system dysfunction in POTS patients. Tilt-
induced CBFv dropped by 26% was observed at the time of loss 
of consciousness in cerebral syncope patients (Grubb et  al., 
1998). In healthy subjects, the drop of CBFv below 30% of the 
baseline is associated with signs of cerebral hypoperfusion 
and drop by 50% of the baseline is associated with syncope 
(Njemanze, 1992).
The criteria for the CBFv changes in OCHOs were derived 
from QASAT. QASAT grades tilt-induced CBFv abnormalities 
into mild–moderate–severe. Moderate CBFv abnormalities were 
chosen as a threshold, since this level of abnormality segregate 
patients with more widespread dysautonomia as seen in dia-
betes and Parkinson disease from mild CBFv abnormalities as 
seen in non-diabetic autonomic neuropathies (Novak, 2015). If 
stricter criteria are used, for example, severe abnormalities on 
the QASAT-CBF, then 49 patients would still satisfy the OCHOs 
criteria. The grading criteria are time dependent. Severe CBFv 
abnormalities are defined as presence at least two out three of the 
following: the drop of CBFv below 70% at the 1st minute, 69% at 
TaBle 3 | clinical variables.
Variable controls OchOs P
SCBFv at supine, cm/s (100%) 104.2 ± 18.1 104.3 ± 19.7 0.974
SCBFv drop from supine at 1st minute of tilt, % of baseline 96.8 ± 5.0 86.5 ± 8.8 <0.0001
SCBFv drop from supine at 5th minute of tilt, % of baseline 96.7 ± 6.3 81.8 ± 8.1 <0.0001
SCBFv drop from supine at 10th minute of tilt, % of baseline 95.3 ± 5.0 77.5 ± 7.8 <0.0001
MCBFv at supine, cm/s (100%) 65.1 ± 10.9 65.1 ± 11.8 0.967
MCBFv drop from supine at 1st minute of tilt, % of baseline 97.9 ± 4.5 84.8 ± 8.9 <0.0001
MCBFv drop from supine at 5th minute of tilt, % of baseline 98.1 ± 6.6 79.6 ± 8.6 <0.0001
MCBFv drop from supine at 10th minute of tilt, % of baseline 95.8 ± 5.6 75.9 ± 8.2 <0.0001
DCBFv at supine, cm/s (100%) 45.5 ± 9.5 45.3 ± 9.7 0.879
DCBFv drop from supine at 1st minute of tilt, % of baseline 99.4 ± 7.6 83.3 ± 13.1 <0.0001
DCBFv drop from supine at 5th minute of tilt, % of baseline 98.8 ± 8.2 77.9 ± 13.1 <0.0001
DCBFv drop from supine at 10th minute of tilt, % of baseline 96.5 ± 8.7 73.7 ± 12.5 <0.0001
SBP supine, mmHg 122.9 ± 15.1 122.6 ± 14.6 0.895
SBP at first minute of tilt, mmHg 123.2 ± 15.4 122.2 ± 14.7 0.643
SBP at fifth minute of tilt, mmHg 122.6 ± 15.4 121.3 ± 14.9 0.532
SBP at 10th minute of tilt, mmHg 121.6 ± 13.9 119.9 ± 14.8 0.412
MBP supine, mmHg 91.1 ± 9.4 90.5 ± 10.6 0.620
MBP at 1st minute of tilt, mmHg 93.2 ± 10.1 93.3 ± 10.4 0.995
MBP at 5th minute of tilt, mmHg 93.2 ± 10.5 91.9 ± 9.7 0.365
MBP at 10th minute of tilt, mmHg 92.1 ± 9.6 90.4 ± 9.7 0.200
DBP supine, mm Hg 75.2 ± 7.6 74.5 ± 9.8 0.560
DBP at 1st minute of tilt, mmHg 78.3 ± 8.5 78.4 ± 8.9 0.923
DBP at 5th minute of tilt, mmHg 78.2 ± 9.3 77.1 ± 8.7 0.391
DBP at 10th minute of tilt, mmHg 77.1 ± 8.40 75.5 ± 8.45 0.187
HR supine, BPM 71.8 ± 11.9 72.5 ± 11.8 0.672
HR at 1st minute of tilt, BPM 78.6 ± 13.2 81.0 ± 13.9 0.209
HR at 5th minute of tilt, BPM 81.3 ± 12.5 84.0 ± 13.9 0.144
HR at 10th minute of tilt, BPM 82.5 ± 12.5 85.8 ± 15.2 0.09
End tidal CO2 supine, mmHg 40.5 ± 2.70 40.1 ± 2.44 0.45
End tidal CO2 at 1st minute of tilt, mmHg 39.5 ± 2.01 39.4 ± 2.1 0.714
End tidal CO2 at 5th minute of tilt, mmHg 38.9 ± 2.05 38.9 ± 2.1 0.985
End tidal CO2 at 10th minute of tilt, mmHg 38.7 ± 1.15 38.5 ± 2.1 0.614
Resistance index supine 0.56 ± 0.08 0.56 ± 0.08 0.909
Resistance index at 1st minute of tilt 0.54 ± 0.08 0.57 ± 0.08 0.0045
Resistance index at 5th minute of tilt 0.54 ± 0.08 0.58 ± 0.08 0.0029
Resistance index at 10th minute of tilt 0.55 ± 0.01 0.58 ± 0.09 0.01
CVR supine, mmHg/cm/s 1.44 ± 0.31 1.45 ± 0.31 0.861
CVR at 1st minute of tilt, mmHg/cm/s 1.49 ± 0.31 1.76 ± 0.40 <0.0001
CVR at 5th minute of tilt, mmHg/cm/s 1.50 ± 0.30 1.85 ± 0.45 <0.0001
CVR at 10th minute of tilt, mmHg/cm/s 1.52 ± 0.32 1.92 ± 0.43 <0.0001
Data are mean ± SD. Percentages are expressed as percent of baseline where baseline is equal to 100%. OCHOs, orthostatic cerebral hypoperfusion syndrome; SCBFv/MCBFv/
DCBFv, systolic/mean/diastolic cerebral blood flow velocity; SBP/MBD/DBP, systolic/mean/diastolic blood pressure; HR, heart rate, CVR, cerebral vascular resistance.
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the 5th minute, or 67% at the 10th minute where the baseline is 
equal to 100%.
Orthostatic cerebral hypoperfusion syndrome affects wide 
range of age groups and more women than men were affected. 
However, this could be due referral bias and needs to be confirmed 
in subsequent studies. Several comorbidities has been found in 
OCHOs, hypertension being the most frequent (21%). Whether 
this is real association between hypertension and OCHOs or it 
reflects referral bias needs to be assessed in further studies.
There are several mechanisms that may lead to cerebral 
hypoperfusion in OCHOs. Cerebral perfusion is controlled by 
a complex system called cerebral autoregulation that determines 
relationship between CBFv and the blood pressure. CBFv is kept 
constant within relatively large variations of the blood pressure by 
adjusting the vascular resistance. Static autoregulation determines 
the average CBFv at a given blood pressure under steady-state 
conditions. Then low CBFv with stable orthostatic blood pressure 
and heart rate indicates failure of cerebral autoregulation such 
as the static cerebral autoregulation is reduced. The mechanism 
associated with the autoregulatory failure in OCHOs can be 
abnormal vasoconstriction at the cerebral arterioles that reduces 
the cerebral flow. Cerebral vasoconstriction was proposed as 
underlying mechanism for reduced orthostatic CBFv in healthy 
subjects and in orthostatic tachycardia syndrome (Dewey et al., 
1974; Njemanze, 1992; Franco Folino, 2007; van Beek et  al., 
2008; Tzeng and Ainslie, 2014). Either sympathetic-mediated 
cerebral vasoconstriction (Immink et  al., 2006) or parasympa-
thetic withdrawal-mediated reduction of nitric-oxide-dependent 
cerebral vasodilatation (Del Pozzi et  al., 2014) were proposed. 
Both mechanisms involve active processes leading to cerebral 
vasoconstriction.
Another mechanism leading to OCHOs may be related to 
ineffective compensation to orthostatic stress. Changing of posi-
tion to standing reduces central blood volume with redistribution 
FigUre 3 | Details of cerebral blood flow velocity (cBFv) in OchOs (right) and in a control subject with normal response to tilt (left). OCHOs subject is 
61-year-old man with history of orthostatic dizziness and neuropathy. During tilt, patient complained on dizziness with headache and he became very tired at the 
end of the tilt. Note progressive decline in CBFv during the tilt pointed by black arrows. Both resistance index (RI) and cerebrovascular resistance (CVR) increased in 
OCHOs while they remained unchanged in control subject during the tilt. The mean blood pressure was stable in both control and OCHOs subject during tilt. The 
heart responses to tilt were preserved in both subjects.
February 2016 | Volume 8 | Article 227
Novak OCHOs
Frontiers in Aging Neuroscience | www.frontiersin.org
to the splanchnic vasculature and lower limbs (Del Pozzi et al., 
2014). It can be hypothesized that excessive reduction of central 
blood volume due to increased venous compliance that reduces 
venous return may reduce cardiac output in OCHOs. The sym-
pathetic activation to orthostatic stress still can compensate for 
reduced cardiac output by increasing sympathetically mediated 
peripheral resistance and, hence, to maintain the orthostatic 
blood pressure, but not enough to maintain the orthostatic 
cerebral flow.
Both OCHOs and some POTS patients share orthostatic drop 
of CBFv without orthostatic hypotension. In contrast to POTS, 
orthostatic tachycardia and orthostatic hyperventilation is not 
feature of OCHOs, hence different mechanisms may play a role. 
Nevertheless, it is possible that a normocapnic POTS (Ocon 
et  al., 2009) is a form of OCHOs with exaggerated heart rate 
response to tilt. Cerebral syncope (Njemanze, 1993; Daffertshofer 
and Hennerici, 1995; Fredman et al., 1995; Grubb et al., 1998) 
also shares similarities with OCHOs. In both syndromes, the 
orthostatic CBFv drops without associated orthostatic hypoten-
sion or bradycardia during the tilt test. Nevertheless, OCHOs 
fundamentally differs from cerebral syncope. The systolic and 
the diastolic CBFv drops in OCHOs indicating either cerebral 
vasoconstriction or a passive loss of intravascular volume (see 
the discussion above). In cerebral syncope, the systolic CBFv is 
elevated and the diastolic CBFv is reduced (Grubb et al., 1998), 
e.g., the pulsatility index (systolic–diastolic CFBv) increases that 
is consistent with cerebral vasodilation (Carey et al., 2002; Ocon 
et al., 2011).
The two most common comorbidities in OCHOs patients 
were hypertension and migraine, combined they represent 35% 
of all OCHOs patients. Both disorders are associated with small 
vessel disease (SVD) (Agostoni and Rigamonti, 2012; Mok and 
Kim, 2015). If combining all disorders found in OCHOs which 
are associated with SVD (hypertension, migraine, diabetes, and 
dyslipidemia), then total 52% of OCHOs patients (some of the 
patients have more than one risk factor) have risk factors for 
SVD. Hence, SVD represents possible link of vascular pathology 
to OCHOs. Nevertheless, this needs to be investigated in further 
studies. Medication is unlikely responsible for results since 
patients taking vasoactive medication were excluded from the 
study.
This study defines the OCHOs as a novel syndrome associated 
with low orthostatic CBFv and stable orthostatic blood pressure, 
heart rate, and respiratory pattern. OCHO, thus, complements 
common orthostatic hemodynamic syndromes, including POTS 
(principal abnormality in heart rate), OH (principal abnormality 
in blood pressure), and OCHOs (principal abnormality in cerebral 
blood flow). Using an orthostatic triad (POTS, OH, and OCHOs) 
classification can set up a useful clinical framework for evaluation 
of orthostatic symptoms. To evaluate patients using the outlined 
classification, it is essential to monitor CBFv in addition to heart 
rate, blood pressure, and respiratory variables during the tilt test.
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Results presented in this paper may have direct clinical signifi-
cance. The concept of OCHOs provides physiologically plausible 
mechanism for unexplained orthostatic dizziness that is very 
common. The proposed concept of OCHOs relies on inexpensive 
technology (transcranial Doppler, heart rate, and blood pressure 
monitors) and normative data are provided.
This study has several limitations. The principal limitation 
is its retrospective character where the OCHOs criteria were 
applied to already acquired data and the exact criteria may not be 
applicable to other population. Second, a referral bias may affect 
selection of subjects and, therefore, the studied population may 
not be representative. Third, a bias could be introduced by using 
the particular transcranial Doppler device since the CBFv values 
may be device dependent (Novak, 2015). Fourth, all CBFv’s 
were acquired by one sonographer (Peter Novak) that was not 
blinded to evaluations. There are potential other biases associ-
ated with a single-center, retrospective study. Only a prospective 
study, preferentially blinded to a sonographer, can resolve these 
limitations.
In conclusion, OCHOs may be a common cause of orthostatic 
dizziness in patients without orthostatic hypotension. Orthostatic 
dizziness in OCHOs is consistent with central nervous system 
hypoperfusion due to low orthostatic CBFv with a failure of 
static cerebral autoregulation most likely due excessive cerebral 
vasoconstriction upon upright posture. Detection of OCHOs is 
straightforward by simultaneous monitoring of hemodynamic 
variables and CBFv during the tilt test.
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